Regencell Bioscience (RGC) had the best year last year by a large-cap US stock in the Nasdaq Composite (IXIC) last year, returning 15,618.6%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | 2025 | 15,618.56% |
EchoStar (SATS) | 2025 | 369.75% |
Lumentum (LITE) | 2025 | 337.96% |
Western Digital (WDC) | 2025 | 282.32% |
IREN (IREN) | 2025 | 266.34% |
Ast Spacemobile (ASTS) | 2025 | 243.57% |
Micron Technology (MU) | 2025 | 236.96% |
Guardant Health (GH) | 2025 | 226.85% |
Seagate Technology (STX) | 2025 | 221.91% |
Nebius (NBIS) | 2025 | 197.56% |
Robinhood Markets (HOOD) | 2025 | 193.46% |
Kratos Defense & Security Solutions (KTOS) | 2025 | 187.86% |
BridgeBio Pharma (BBIO) | 2025 | 175.24% |
Rocket Lab USA (RKLB) | 2025 | 174.32% |
Warner Bros Discovery (WBD) | 2025 | 170.36% |
Insmed (INSM) | 2025 | 148.63% |
Symbotic (SYM) | 2025 | 146.17% |
Avidity Biosciences (RNA) | 2025 | 143.6% |
Lam Research (LRCX) | 2025 | 137.58% |
Palantir Technologies (PLTR) | 2025 | 133.27% |
Nextracker Inc Class A Common Stock (NXT) | 2025 | 132.98% |
Tower Semiconductor (TSEM) | 2025 | 125.81% |
Ionis Pharmaceuticals (IONS) | 2025 | 123.92% |
Elbit Systems (ESLT) | 2025 | 121.3% |
Credo Technology (CRDO) | 2025 | 109.57% |
Large-cap stocks are treated as having a market cap of $10B+.
